Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MARK pathways

Journal of Cellular Biochemistry

Volumn 100, Issue 1, 2007, Pages 204-216

  Auld, Corinth A ^a   Caccia, Carla D ^a   Morrison, Ron F ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Adipocyte; Cell cycle; Obesity; Proliferation

Indexed keywords

INSULIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HORMONE ACTION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-METHYL-3-ISOBUTYLXANTHINE; 1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEXAMETHASONE; HORMONES; HYPERPLASIA; INSULIN; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; RNA STABILITY; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION, GENETIC;

EID: 33845602526     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21063     Document Type: Article

References (36)

1. Andreu EJ, Lledo E, Poch E, Ivorra C, Albero MP, Martinez-Climent JA, Montiel-Duarte C, Rifon J, Perez-Calvo J, Arbona C, Prosper F, Perez-Roger I. 2005. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res 65:3264-3272.
2. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. 2004. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428:190-193.
3. Brennan P, Mehl AM, Jones M, Rowe M. 2002. Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene 21:1263-1271.
4. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
5. Carrano AC, Eytan E, Hershko A, Pagano M. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193-199.
6. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J. 2002. E2Fs regulate adipocyte differentiation. Dev Cell 3:39-49.
7. Flory E, Hoffmeyer A, Smola U, Rapp UR, Bruder JT. 1996. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J Virol 70:2260-2268.
8. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A. 2001. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 3:321-324.
9. Gao N, Zhang Z, Jiang BH, Shi X. 2003. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 310:1124-1132.
10. Hager A, Sjorstrom L, Arvidsson B, Bjorntorp P, Smith U. 1978. Adipose tissue cellularity in obese school girls before and after dietary treatment. Am J Clin Nutr 31: 68-75.
11. Hao B, Zheng N, Schulman BA, Wu G, Miller JJ, Pagano M, Pavletich NP. 2005. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Mol Cell 20:9-19.
12. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. 2001. The biology of white adipocyte proliferation. Obes Rev 2:239-254.
13. Imaki H, Nakayama K, Delehouzee S, Handa H, Kitagawa M, Kamura T, Nakayama KI. 2003. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res 63:4607-4613.
14. Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW, Burgering BM. 2002. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22:2025-2036.
15. Landsberg RL, Sero JE, Danielian PS, Yuan TL, Lee EY, Lees JA. 2003. The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity. Proc Natl Acad Sci USA 100:2456-2461.
16. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271:20608-20616.
17. Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H, Sun H. 2001. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol 11:263-267.
18. Mandenoff A, Lenoir T, Apfelbaum M. 1982. Tardy occurrence of adipocyte hyperplasia in cafeteria-fed rat. Am J Physiol 242:R349-R351.
19. Morrison RF, Farmer SR. 1999. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem 274:17088-17097.
20. Naaz A, Holsberger DR, Iwamoto GA, Nelson A, Kiyokawa H, Cooke PS. 2004. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 18:1925-1927.
21. Pettersson P, Van R, Karlsson M, Bjorntorp P. 1985. Adipocyte precursor cells in obese and nonobese humans. Metabolism 34:808-812.
22. Prins JB, O'Rahilly S. 1997. Regulation of adipose cell number in man. Clin Sci (Lond) 92:3-11.
23. Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, Tavares MJ, Miele L, Cardoso AA, Classon M, Carlesso N. 2005. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 202:157-168.
24. Shah SA, Potter MW, Hedeshian MH, Kim RD, Chari RS, Callery MP. 2001. PI-3′ kinase and NF-kappaB cross-signaling in human pancreatic cancer cells. J Gastrointest Surg 5:603-612.
25. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. 1988. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263:9402-9408.
26. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W. 1999. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1:207-214.
27. Tang QQ, Otto TC, Lane MD. 2003a. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA 100:850-855.
28. Tang QQ, Otto TC, Lane MD. 2003b. Mitotic clonal expansion: A synchronous process required for adipogenesis. Proc Natl Acad Sci USA 100:44-49.
29. Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. 2001. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 61:589-593.
30. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9:661-664.
31. Villena JA, Vinas O, Mampel T, Iglesias R, Giralt M, Villarroya F. 1998. Regulation of mitochondrial biogenesis in brown adipose tissue: Nuclear respiratory factor-2/GA-binding protein is responsible for the transcriptional regulation of the gene for the mitochondrial ATP synthase beta subunit. Biochem J 331(Pt 1):121-127.
32. Wang W, Ungermannova D, Jin J, Harper JW, Liu X. 2004. Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. Oncogene 23:1064-1075.
33. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG, Jr. 2004. Degradation of the SCF component Skp2 in cell-cycle phase Gl by the anaphase-promoting complex. Nature 428:194-198.
34. Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F, Krek W. 2000. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: Evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J 19:5362-5375.
35. Zhang L, Wang C. 2005. F-box protein Skp2: A novel transcriptional target of E2F. Oncogene 25:2615-2627.
36. Zhang YW, Nakayama K, Nakayama K, Morita I. 2003. A novel route for connexin 43 to inhibit cell proliferation: Negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res 63:1623-1630.